Y-mAbs Therapeutics, Inc.
YMABDelisted Sep 16, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001722964
Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Y-mAbs Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 117 | 100 | −17 |
| Shares | 26.5M | 26.1M | −370.2K (−1.4%) |
| Value | $804.8M | $886.9M | +$82.1M (+10.2%) |
New holders (13)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 144,300 | $4.88M | 0.75% |
| Alps Advisors Inc | 57,386 | $1.94M | 0.02% |
| Hillsdale Investment Management Inc. | 26,699 | $902.0K | 0.07% |
| ExodusPoint Capital Management, LP | 17,000 | $575.0K | 0.01% |
| DnB Asset Management AS | 12,815 | $433.1K | 0.00% |
| Marshall Wace, LLP | 12,310 | $415.0K | 0.00% |
| Marshall Wace North America L.P. | 8,204 | $277.0K | 0.00% |
| Boothbay Fund Management, LLC | 7,935 | $268.0K | 0.01% |
| Arizona State Retirement System | 7,065 | $239.0K | 0.00% |
| Amalgamated Bank | 6,599 | $223.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 62 | $2.00K | 0.00% |
| Signaturefd, LLC | 29 | $1.00K | 0.00% |
| Red Door Wealth Management, LLC | 40 | $1.00K | 0.00% |
Sold out (30)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.